111 related articles for article (PubMed ID: 37352900)
1. Synergy between imputed genetic pathway and clinical information for predicting recurrence in early stage non-small cell lung cancer.
Timilsina M; Fey D; Buosi S; Janik A; Costabello L; Carcereny E; Abreu DR; Cobo M; Castro RL; Bernabé R; Minervini P; Torrente M; Provencio M; Nováček V
J Biomed Inform; 2023 Aug; 144():104424. PubMed ID: 37352900
[TBL] [Abstract][Full Text] [Related]
2. Integration of Clinical Information and Imputed Aneuploidy Scores to Enhance Relapse Prediction in Early Stage Lung Cancer Patients.
Timilsina M; Buosi S; Fey D; Janik A; Torrente M; Provencio M; Bermu Dez AC; Carcereny E; Costabello L; Abreu DRI; Cobo M; Castro RLP; Bernabe R; Guirado DM; Minervini P; Nova Cˇek VI
AMIA Annu Symp Proc; 2022; 2022():1062-1071. PubMed ID: 37128408
[TBL] [Abstract][Full Text] [Related]
3. Boosting predictive models and augmenting patient data with relevant genomic and pathway information.
Buosi S; Timilsina M; Torrente M; Provencio M; Fey D; Nováček V
Comput Biol Med; 2024 May; 174():108398. PubMed ID: 38608322
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer.
Janik A; Torrente M; Costabello L; Calvo V; Walsh B; Camps C; Mohamed SK; Ortega AL; Nováček V; Massutí B; Minervini P; Campelo MRG; Del Barco E; Bosch-Barrera J; Menasalvas E; Timilsina M; Provencio M
JCO Clin Cancer Inform; 2023 Jul; 7():e2200062. PubMed ID: 37428988
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel mRNA signature for predicting early relapse in non-small cell lung cancer.
Lin J; Weng J; Lin S; Lin C; Huang J; Zhang C; Zhang S; Dong C; Ji H; Ke X
Jpn J Clin Oncol; 2021 Aug; 51(8):1277-1286. PubMed ID: 34037221
[TBL] [Abstract][Full Text] [Related]
6. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
[TBL] [Abstract][Full Text] [Related]
7. A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
Hindocha S; Charlton TG; Linton-Reid K; Hunter B; Chan C; Ahmed M; Robinson EJ; Orton M; Ahmad S; McDonald F; Locke I; Power D; Blackledge M; Lee RW; Aboagye EO
EBioMedicine; 2022 Mar; 77():103911. PubMed ID: 35248997
[TBL] [Abstract][Full Text] [Related]
8. Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis.
Yu L; Tao G; Zhu L; Wang G; Li Z; Ye J; Chen Q
BMC Cancer; 2019 May; 19(1):464. PubMed ID: 31101024
[TBL] [Abstract][Full Text] [Related]
9. Machine learning application in personalised lung cancer recurrence and survivability prediction.
Yang Y; Xu L; Sun L; Zhang P; Farid SS
Comput Struct Biotechnol J; 2022; 20():1811-1820. PubMed ID: 35521553
[TBL] [Abstract][Full Text] [Related]
10. Machine learning for predicting colon cancer recurrence.
Kayikcioglu E; Onder AH; Bacak B; Serel TA
Surg Oncol; 2024 Jun; 54():102079. PubMed ID: 38688191
[TBL] [Abstract][Full Text] [Related]
11. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
Zou M; Liu Z; Zhang XS; Wang Y
Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
[TBL] [Abstract][Full Text] [Related]
12. Clinical decision support tool for breast cancer recurrence prediction using SHAP value in cooperative game theory.
Liu Y; Fu Y; Peng Y; Ming J
Heliyon; 2024 Jan; 10(2):e24876. PubMed ID: 38312672
[TBL] [Abstract][Full Text] [Related]
13. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
Wang K; Li Y; Wang J; Chen R; Li J
Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782
[TBL] [Abstract][Full Text] [Related]
14. Explainable ensemble machine learning model for prediction of 28-day mortality risk in patients with sepsis-associated acute kidney injury.
Yang J; Peng H; Luo Y; Zhu T; Xie L
Front Med (Lausanne); 2023; 10():1165129. PubMed ID: 37275353
[TBL] [Abstract][Full Text] [Related]
15. Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non-small-cell lung carcinoma.
Luo R; Song J; Xiao X; Xie Z; Zhao Z; Zhang W; Miao S; Tang Y; Ran L
Aging (Albany NY); 2020 Jul; 12(14):14649-14676. PubMed ID: 32723974
[TBL] [Abstract][Full Text] [Related]
16. How platinum-induced nephrotoxicity occurs? Machine learning prediction in non-small cell lung cancer patients.
Huang SH; Chu CY; Hsu YC; Wang SY; Kuo LN; Bai KJ; Yu MC; Chang JH; Liu EH; Chen HY
Comput Methods Programs Biomed; 2022 Jun; 221():106839. PubMed ID: 35550456
[TBL] [Abstract][Full Text] [Related]
17. An interpretable machine learning prognostic system for risk stratification in oropharyngeal cancer.
Alabi RO; Almangush A; Elmusrati M; Leivo I; Mäkitie AA
Int J Med Inform; 2022 Dec; 168():104896. PubMed ID: 36279655
[TBL] [Abstract][Full Text] [Related]
18. Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer.
Shen H; Jin Y; Zhao H; Wu M; Zhang K; Wei Z; Wang X; Wang Z; Li Y; Yang F; Wang J; Chen K
BMC Med; 2022 Dec; 20(1):480. PubMed ID: 36514063
[TBL] [Abstract][Full Text] [Related]
19. A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types.
Mettu RK; Wan YW; Habermann JK; Ried T; Guo NL
Int J Biol Markers; 2010; 25(4):219-28. PubMed ID: 21161944
[TBL] [Abstract][Full Text] [Related]
20. The value of nodal information in predicting lung cancer relapse using 4DPET/4DCT.
Li H; Becker N; Raman S; Chan TC; Bissonnette JP
Med Phys; 2015 Aug; 42(8):4727-33. PubMed ID: 26233200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]